Jinshi Technology

Developer of gene sequencing technology. The company is focusing on the development of fourth-generation (nanopore) gene sequencers and reagents by using nanopore gene sequencing technology that provides current signals generated by the interaction of protein nanopores and nucleic acid bases. The device can convert the base sequences of DNA and RNA into current signals that can be easily measured, and achieve convenient and fast sequencing goals at the single-molecule level. Founded in 2017, hea The company operates in Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics. Its business models include Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing, Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing. Founded in 2017. Headquartered in China, Chengdu. The company has raised funding at the Series B stage. Backed by investors including China Growth Capital, Sequoia Capital, Sinopharm Capital, Rongan Venture, Grand Mount Capital, Qianhai Derun Capital Management, Potential Capital, Co-win Ventures.